VIRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Vir Biotechnology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$10.21+0.25 (+2.51%)
Close on Oct 19, 2026
- Market cap
- $1.72B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Vir Biotechnology's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 9, 2026 | Oct 14, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 8, 2026 | Oct 8, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2026 | Oct 1, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 20, 2026 | Jul 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2026 | Jun 10, 2026 | SEC EDGAR |
| Current report | 8-K | May 25, 2026 | May 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Apr 16, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2026 | Apr 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2026 | Mar 4, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Mar 2, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2026 | Feb 26, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2025 | Jul 24, 2025 | SEC EDGAR |
| Current report | 8-K | May 29, 2025 | May 29, 2025 | SEC EDGAR |
| Current report | 8-K | May 9, 2025 | May 9, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 29, 2025 | Apr 17, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 24, 2025 | Jan 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2025 | Jan 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 4, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 6, 2024 | Sep 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2024 | Jun 26, 2024 | SEC EDGAR |